Although many CSC biomarkers (e.g., CD133, CD13, CD24, EpCAM, Nanog) have been identified in HCC, it is still unclear which biomarker truly represents CSCs and the molecular signaling events that regulate cellular hierarchy, stemness, and success in defining key CSC-specific genes [8-11]. Here, NANOG is linked to hepatocellular carcinoma.